Bcl-2-associated X protein (BAX) (BAX)

Bcl-2-associated X protein (BAX) is a pivotal pro-apoptotic member of the Bcl-2 family and a central executioner of the intrinsic mitochondrial apoptosis machinery. In healthy cells, BAX typically exists as an inactive monomer in the cytosol or peripherally associated with the mitochondrial outer membrane. Upon activation by cellular stress or pro-apoptotic signals, BAX undergoes significant conformational changes, translocates to the mitochondria, and forms oligomeric pores in the outer membrane. This process, termed mitochondrial outer membrane permeabilization (MOMP), triggers the release of cytochrome c and other factors that activate the caspase cascade, leading to programmed cell death. Dysregulation of BAX is critically involved in various pathologies; for instance, its suppression allows cancer cells to evade apoptosis and develop drug resistance, while its excessive activation contributes to neurodegenerative diseases and myocardial injury. Therapeutic interventions targeting BAX include direct small-molecule activators designed to trigger apoptosis in malignant cells and indirect modulators like BH3 mimetics that release BAX from inhibitory anti-apoptotic proteins. Conversely, BAX inhibitors are being investigated for their potential to prevent pathological cell loss in conditions such as stroke and heart failure.

Other names

BCL2L4Apoptosis regulator BAXBCL2-associated X proteinBcl-2-like protein 4

Direct activators bind to the N-terminal activation site or BH3-binding groove of BAX to induce conformational changes, translocation to the mitochondria, and oligomerization into pores. Indirect modulators, such as BH3 mimetics, inhibit anti-apoptotic proteins (e.g., BCL-2, BCL-XL), thereby releasing BAX from sequestration to execute mitochondrial outer membrane permeabilization.